These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 31905329)

  • 21. Cross-Reactive Flavivirus Antibody: Friend and Foe?
    Maciejewski S; Pierson TC
    Cell Host Microbe; 2018 Nov; 24(5):622-624. PubMed ID: 30439339
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mechanisms of evasion of the type I interferon antiviral response by flaviviruses.
    Diamond MS
    J Interferon Cytokine Res; 2009 Sep; 29(9):521-30. PubMed ID: 19694536
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characterization of the RepliVax platform for replication-defective flavivirus vaccines.
    Rumyantsev AA; Giel-Moloney M; Liu Y; Gao QS; Zhang ZX; Catalan J; Frolov I; Almond J; Kleanthous H; Pugachev KV
    Vaccine; 2011 Jul; 29(32):5184-94. PubMed ID: 21620917
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Many Faces of a Dynamic Virion: Implications of Viral Breathing on Flavivirus Biology and Immunogenicity.
    Dowd KA; Pierson TC
    Annu Rev Virol; 2018 Sep; 5(1):185-207. PubMed ID: 30265634
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tick-borne flaviviruses.
    Gritsun TS; Nuttall PA; Gould EA
    Adv Virus Res; 2003; 61():317-71. PubMed ID: 14714436
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ilheus and Saint Louis encephalitis viruses elicit cross-protection against a lethal Rocio virus challenge in mice.
    Amarilla AA; Fumagalli MJ; Figueiredo ML; Lima-Junior DS; Santos-Junior NN; Alfonso HL; Lippi V; Trabuco AC; Lauretti F; Muller VD; Colón DF; Luiz JPM; Suhrbier A; Setoh YX; Khromykh AA; Figueiredo LTM; Aquino VH
    PLoS One; 2018; 13(6):e0199071. PubMed ID: 29897990
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Oral Delivery of a DNA Vaccine Expressing the PrM and E Genes: A Promising Vaccine Strategy against Flavivirus in Ducks.
    Huang J; Jia R; Shen H; Wang M; Zhu D; Chen S; Liu M; Zhao X; Wu Y; Yang Q; Yin Z; Cheng A
    Sci Rep; 2018 Aug; 8(1):12360. PubMed ID: 30120326
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Flavivirus infections in tropical areas].
    Igarashi A
    Uirusu; 1993 Jun; 43(1):67-76. PubMed ID: 8236844
    [No Abstract]   [Full Text] [Related]  

  • 29. Immune mediated and inherited defences against flaviviruses.
    Brinton MA; Kurane I; Mathew A; Zeng L; Shi PY; Rothman A; Ennis FA
    Clin Diagn Virol; 1998 Jul; 10(2-3):129-39. PubMed ID: 9741638
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Live flavivirus vaccines: reasons for caution.
    Seligman SJ; Gould EA
    Lancet; 2004 Jun; 363(9426):2073-5. PubMed ID: 15207960
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evidence that a mechanism for efficient flavivirus budding upregulates MHC class I.
    Lobigs M; Müllbacher A; Lee E
    Immunol Cell Biol; 2004 Apr; 82(2):184-8. PubMed ID: 15061772
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Construction of a highly efficient CRISPR/Cas9-mediated duck enteritis virus-based vaccine against H5N1 avian influenza virus and duck Tembusu virus infection.
    Zou Z; Huang K; Wei Y; Chen H; Liu Z; Jin M
    Sci Rep; 2017 May; 7(1):1478. PubMed ID: 28469192
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Research advances in plant-made flavivirus antigens.
    Martínez CA; Giulietti AM; Talou JR
    Biotechnol Adv; 2012; 30(6):1493-505. PubMed ID: 22480936
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Flavivirus Receptors: Diversity, Identity, and Cell Entry.
    Laureti M; Narayanan D; Rodriguez-Andres J; Fazakerley JK; Kedzierski L
    Front Immunol; 2018; 9():2180. PubMed ID: 30319635
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Developing vaccines against flavivirus diseases: past success, present hopes and future challenges.
    Stephenson JR
    Novartis Found Symp; 2006; 277():193-201; discussion 201-5, 251-3. PubMed ID: 17319163
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Variable effects of the co-administration of a GM-CSF-expressing plasmid on the immune response to flavivirus DNA vaccines in mice.
    Chen H; Gao N; Wu J; Zheng X; Li J; Fan D; An J
    Immunol Lett; 2014 Nov; 162(1 Pt A):140-8. PubMed ID: 25128840
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Toll-Like Receptors and RIG-I-Like Receptors Play Important Roles in Resisting Flavivirus.
    Guo HY; Zhang XC; Jia RY
    J Immunol Res; 2018; 2018():6106582. PubMed ID: 29888293
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The immune response against flaviviruses.
    Slon Campos JL; Mongkolsapaya J; Screaton GR
    Nat Immunol; 2018 Nov; 19(11):1189-1198. PubMed ID: 30333606
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Protective immune response against newly emerging goose tembusu virus infection induced by immunization with a recombinant envelope protein.
    Zhao D; Huang X; Han K; Liu Y; Yang J; Liu Q; An F; Li Y
    Lett Appl Microbiol; 2015 Oct; 61(4):318-24. PubMed ID: 26108865
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Safety testing for neurovirulence of novel live, attenuated flavivirus vaccines: infant mice provide an accurate surrogate for the test in monkeys.
    Monath TP; Myers GA; Beck RA; Knauber M; Scappaticci K; Pullano T; Archambault WT; Catalan J; Miller C; Zhang ZX; Shin S; Pugachev K; Draper K; Levenbook IS; Guirakhoo F
    Biologicals; 2005 Sep; 33(3):131-44. PubMed ID: 15975826
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.